Publications by authors named "James Whitlock"

Claim this Profile
C
Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.
Robert Siddaway, Aida I Glembocki, Anthony Arnoldo, Jordan Staunton, Anthony P Y Liu, James A Whitlock

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to Enrollment.
Cielle Stapleton, Ashley Doka, Lucie Pecheux, Pauline Tibout, Kathy Brodeur-Robb, James A Whitlock

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Sandra Judd, Gabriel Revon-Riviere, Stephanie A Grover, Rebecca J Deyell, Magimairajan Issai Vanan, James A Whitlock

Cancer Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience.
Gabriel Revon-Riviere, Leah C Young, Elizabeth A Stephenson, Kathy Brodeur-Robb, Sarah Cohen-Gogo, James A Whitlock

Paediatr Child Health· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a partnership to improve health care delivery to children <18 years with cancer and blood disorders in the English-speaking Caribbean: lessons from the SickKids-Caribbean Initiative (SCI).
Michelle Reece-Mills, Curt Bodkyn, Jo-Anna B Baxter, Upton Allen, Cheryl Alexis, James A Whitlock

Lancet Reg Health Am· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Laura E Hogan, Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, James A Whitlock

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis.
James A Whitlock, Birgit Geoerger, Ira J Dunkel, Michael Roughton, Jeea Choi

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Clinical Correlation of PD-1/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis.
Sneha Tandon, Sheila Weitzman, Brooklyn Joyce, Bryan Mcguire, Derek Stephens, James Whitlock

Mediterr J Hematol Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, James A Whitlock

Nat Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive Analysis of Forces Applied by Trained Clinicians During 2-Handed Instrument-Assisted Soft Tissue Mobilization.
Taylor C Stevenson, James A Whitlock, Nickolai Martonick, Scott W Cheatham, Ashley Reeves

J Athl Train· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric V600-Mutant Low-Grade Glioma.
Eric Bouffet, Birgit Geoerger, Christopher Moertel, James A Whitlock, Isabelle Aerts

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, John M Goldberg, Lewis B Silverman

Pediatr Blood Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Sarah K Tasian, Lewis B Silverman, James A Whitlock, Richard Sposto, Joseph P Loftus

Haematologica· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.
Arif Manji, Yvan Samson, Rebecca J Deyell, Donna L Johnston, Victor A Lewis, James A Whitlock

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instrument-Assisted Soft Tissue Mobilization Forces Applied by Trained Clinicians During a Simulated Treatment.
Nickolai J P Martonick, Ashley J Reeves, James A Whitlock, Taylor C Stevenson, Scott W Cheatham

J Sport Rehabil· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Paul G Kemps, Jennifer Picarsic, Benjamin H Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, James A Whitlock

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
Catherine Goudie, Leora Witkowski, Noelle Cullinan, Lara Reichman, Ian Schiller, James A Whitlock

JAMA Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy.
Tony H Truong, Cristian Jinca, Georg Mann, Smaranda Arghirescu, Jochen Buechner, James A Whitlock

Front Pediatr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1.5 Tesla Magnetic Resonance Imaging Features of Canine Intracranial Intra-axial Hematomas.
James Whitlock, Andrew Holdsworth, Carles Morales, Laurent Garosi, Inés Carrera

Front Vet Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura E Hogan, James A Whitlock

JAMA· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of cytological quality between fine-needle aspiration and non-aspiration techniques for obtaining ultrasound-guided samples from canine and feline lymph nodes.
James Whitlock, Olivier Taeymans, Paola Monti

Vet Rec· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.
Nirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J Fry, James A Whitlock

Pediatr Blood Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
Sneha Tandon, Mary Shago, Scott Davidson, Nisha Kanwar, Fabio Fuligni, James Whitlock

Cancer Genet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.
Franco Locatelli, James A Whitlock, Christina Peters, Christiane Chen-Santel, Victoria Chia

Leukemia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Go with the flow: simplified MRD in LMIC ALL.
James A Whitlock

Blood· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis